The global Continuous Renal Replacement Therapy Market Size was USD 1.3 billion in 2021 and is predicted to grow to USD 2.6 billion by 2031, with a CAGR of 7.7% during the period of 2022 to 2031. The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chain, regional landscape, and competitive scenario.
Allied Market Research published a report, titled, ‘Continuous Renal Replacement Therapy Market by Product (Dialysates and Replacement Fluids, Disposables, CRRT Systems), by Modality (Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodiafiltration (CVVHDF), Continuous Venovenous Haemodialysis (CVVHD), Slow Continuous Ultrafiltration (SCUF)), by Age Group (Adults, Pediatrics): Global Opportunity Analysis and Industry Forecast, 2022-2031.’
Request a Sample Copy of the Report: https://www.alliedmarketresearch.com/request-sample/12288
Drivers and Opportunities
Surge in prevalence of kidney-related diseases, demand for continuous renal replacement therapy, rise in geriatric population, and increase in technologically advanced CRRT products for pediatrics drive the growth of the global continuous renal replacement therapy market. However, high cost associated with CRRT devices and the lack of awareness regarding continuous renal replacement therapy in developing countries due to inadequate funding, poor healthcare infrastructure, insufficient human resources, and geographic distance hamper the market growth. On the other hand, rise in government initiatives for regulatory approval of CRRT offer potential opportunities for the market growth.
Key Players of Global Continuous Renal Replacement Therapy Market Report–
- Fresenius Medical Care
- Baxter International
- Toray Industries Inc.
- SWS Hemodialysis Care
- Nipro Corporation
- Ningbo Tianyi Medical Devices
- NIKKISO Co. Ltd.
- Medtronic Plc.
- Medites Pharma spol. s.r.o
- Medical Components Inc.
- Medica S.p.A
- Infomed SA
- Chongqing Shanwaishan Science and Technology
- Braun Melsungen Ag
- Asahi Kasei Corporation
- Anjue Medical Equipment Co. Ltd.
Global Continuous Renal Replacement Therapy Market Segmentation: –
Based on product, the dialysates and replacement fluids segment was the largest market in 2021, contributing to nearly three-fifths of the global continuous renal replacement therapy market, and is expected to maintain its leadership status during the forecast period. The same segment is projected to witness the fastest CAGR of 8.1% from 2022 to 2031. This is attributed to rise in the incidence of acute kidney injury which has increased the demand for continuous renal replacement therapy.
Based on modality, the continuous venovenous hemofiltration (CVVH) segment held nearly one-third of the global continuous renal replacement therapy market share in 2021, and is expected to maintain its leadership status during the forecast period. CVVH is widely used to remove large volumes of fluid while avoiding the hypotensive episodes caused by intermittent hemodialysis. However, the continuous venovenous hemodiafiltration (CVVHDF) segment is projected to witness the highest CAGR of 8.4% from 2022 to 2031. CVVHD is an effective treatment for patients suffering from acute renal failure.
Based on age group, the adults segment contributed to nearly two-thirds of the global continuous renal replacement therapy market in 2021 and is expected to maintain its dominance during the forecast period. The same segment is projected to witness the fastest CAGR of 8.0% from 2022 to 2031. The growth of the segment is attributed to various regulatory approvals for the adult CRRT, and rise in development of novel products for CRRT. Along with this, adoption of several growth strategies by the market players create lucrative opportunities in the segment.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/12288
Asia-Pacific to maintain its lead position during the forecast period
Based on region, the market in Asia-Pacific held the largest market share of around one-third of the global continuous renal replacement therapy market in 2021, and is expected to maintain its lead position during the forecast period. The same segment is projected to manifest the fastest CAGR of 8.8% from 2022 to 2031. This is primarily attributed to the increase in number of initiatives along with rise in investments in R&D of CRRT products. In addition, increased focus of leading manufacturers on expanding their geographical presence and rise in healthcare expenditure drives the growth in the region.
By Region Outlook
- North America
(U.S., Canada, Mexico)
(Germany, France, UK, Italy, Spain, Rest of Europe)
(Japan, China, India, Rest of Asia-Pacific)
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2031?
- How big is the global & regional market in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
- Which region has more opportunities?
Have Any Query? Ask Our Experts: https://www.alliedmarketresearch.com/connect-to-analyst/12288
Other Top Trending Reports:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
205, Portland, OR 97220
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060